AtScale Collaborates with Dataiku to Deliver on the Promise of Everyday AI
Combined Platform Gives Enterprises the Power to Fully Enable Data-Driven Decision Making and Ensure AI…
News
ThoughtSpot Acquires Mode Analytics for $200M to Empower Data Teams to Redefine Business Intelligence with Trusted Generative AI
ThoughtSpot ThoughtSpot acquires Mode for $200M With Mode and ThoughtSpot, data teams can use a…
Strata Launches Real-Time Workforce Management Solution at HFMA Annual Conference
New tool operationalizes data to empower trusted decision-making for healthcare’s frontline leaders CHICAGO, June 26,…
KWESST Provides Update on Key Revenue Opportunities
Ottawa, Ontario–(Newsfile Corp. – June 26, 2023) – KWESST Micro Systems Inc. (TSXV: KWE) (TSXV:…
Hypebeast Ltd. (0150.HK) reports year-end financial results
HONG KONG, Jun 26, 2023 – (ACN Newswire) – Hypebeast Limited (Stock Code: 0150.HK) is…
Report: NAI Global Remote and Hybrid Work Trends Survey Results
NEW YORK, Jun 26, 2023 – (ACN Newswire) – NAI Global has released survey results…
Vida Health Successfully Reduces A1C Levels Among Low-Income Medicare Advantage Members
New outcomes demonstrate the effectiveness of Vida interventions regardless of socioeconomic barriers. SAN FRANCISCO–(BUSINESS WIRE)–New…
Smart Eye Signs Breakthrough Deal for AIS Driver Monitoring System for Fleets with Linde
Smart Eye will deliver its complete hardware and software Driver Monitoring System (DMS) to Linde…
NCR Announces Filing of Form 10 Registration Statement for Planned Spin-Off of ATM Company
ATLANTA–(BUSINESS WIRE)–NCR Corporation (NYSE: NCR), a leading enterprise technology provider, today announced the filing of…
Oncotarget Publishes New Data by Lantern Pharma, an AI Company Developing Cancer Therapies, Further Supporting Clinical Advancement of LP-284, a Novel Synthetically Lethal Drug Candidate for Non-Hodgkin’s Lymphomas
Non-Hodgkin’s lymphoma (NHL) is the seventh leading cause of cancer in the US, with 20-40%…
Sorrento Announces the Full Enrollment of the Pivotal Phase 3 Trial with Olgotrelvir (OVYDSOTM) (STI-1558), a Second Generation Oral Mpro Inhibitor, as a Standalone Treatment for COVID-19
The Phase 3 study of Ovydso was initiated in China in February 2023 and enrolled…
Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder
Promissory note extends cash runway into early Q3 2023 OLPRUVA™ expected to be available by…
Cerevance Announces Presentation at the Gordon Research Conference: Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases
BOSTON, June 26, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes
VANCOUVER, British Columbia, June 26, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes
CAMBRIDGE, Mass., June 26, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society Symposium
ART12.11, a novel and patented cocrystal of CBD reverses the impact of chronic stress on outcomes…
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
Financing led by Nextech and includes participation from EcoR1 Capital, Frazier Life Sciences, Venrock Healthcare…
ABVC BioPharma, Inc. Announces New CEO as It Targets Further Growth
FREMONT, CA, June 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage…
Panbela Announces Poster Presentation at the Endocrine Society Meeting: Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 Diabetes
MINNEAPOLIS, June 26, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…